Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 3Phase 1/2 2Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 15Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Glioblastoma 7Esophageal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Burkitt Lymphoma 7Uterine Cervical Neoplasms 6Rhabdomyosarcoma 6Esophageal Squamous Cell Carcinoma 5Squamous Cell Carcinoma of Head and Neck 4Urinary Bladder Neoplasms 3Sarcoma 3Rhabdomyosarcoma, Embryonal 3Rectal Neoplasms 3Neoplasm Metastasis 3Medulloblastoma 3Lymphoma, Follicular 3Lung Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Adenocarcinoma of Lung 3Vaginal Neoplasms 2Rhabdomyosarcoma, Alveolar 2Prostate Adenocarcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2

Interventions

Rituximab 23Cyclophosphamide 11Radiotherapy 8Prednisone 8Vincristine 7Doxorubicin 7Lenalidomide 6Bendamustine Hydrochloride 5Chlorambucil 4Peripheral Blood Stem Cell Transplantation 3Filgrastim 3obinutuzumab 2liposomal amphotericin B 2idelalisib 2ibrutinib 2fludarabine phosphate 2VAP-cyclo protocol 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Interferon-alpha 2Idarubicin 2Epoetin Alfa 2Early Intervention, Educational 2Cyclosporine 2Busulfan 2zanubrutinib 1tafasitamab 1parsaclisib 1orelabrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, B-Cell, Marginal Zone × Radiation × Clear all
NCT07029217 2026-02-17

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting
375 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡